Xanthohumol {90000201}
Parent: | [ ] |
---|---|
Definition: | Xanthohumol |
Queue: | [ ] |
Initialisation date: | 2021-09-14 |
---|---|
Specification: | |
[ ] | |
Source: | |
[ ] |
Structural Type: | [ ] |
---|---|
Functional Type: | Energy Source |
Function: | Anti-obesity |
Notes:
[ ]
Shared Reference Notes
- [1.1] [#Xanthohumol supplementation]
- XN supplementation > decreased plasma insulin concentrations > improved Insulin Resistance. - The intestinal microbiota > metabolizes XN into bioactive compounds, including dihydroxanthohumol > anti-obesity. - XN > increased the relative abundance of three bacteria, Akkermansia muciniphila, Parabacteroides goldsteinii and Alistipes finegoldii. - [1.2]
- some of the positive outcomes of XN are accomplished by increasing #Akkermansia muciniphila, which we also found increased by TXN - [#Metabolic associated fatty liver disease] - XN also exhibits hepatoprotective effects in animal models of MAFLD and other liver-damaging conditions
- [#Metabolic Dysfunction-associated Steatohepatitis] - XN and even more so, TXN, attenuates hepatosteatosis by acting as antagonists of PPARγ
- [#Metabolic syndrome] - Xanthohumol (XN) and its derivatives mitigate diet-induced #Obesity-related characteristics of MetS in mice by improving impaired #Glucose and lipid metabolism
- - TXN treatment also reduced levels of inflammation-inducing microbes, such as #Oscillibacter valericigenes, that lead to adverse metabolic phenotypes.
- - TXN attenuates macrophage inflammatory processes in adipose tissue.
References Notes
[ ]